id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1237-0006,FDA,FDA-2012-E-1237,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PERJETA",Notice,General Notice,2014-05-19T04:00:00Z,2014,5,2014-05-19T04:00:00Z,,2014-05-19T14:26:52Z,2014-11515,0,0,0900006481703551
FDA-2012-E-1237-0005,FDA,FDA-2012-E-1237,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-05-02T04:00:00Z,2014,5,2014-05-02T04:00:00Z,,2014-05-02T19:17:01Z,,0,0,09000064816de8fc
FDA-2012-E-1237-0004,FDA,FDA-2012-E-1237,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-30T04:00:00Z,2014,3,2014-03-30T04:00:00Z,,2014-03-30T04:05:37Z,,0,0,090000648168f914